Enervit Logo

Enervit

Develops sports nutrition, functional foods, and wellness supplements.

ENV | XMIL

Overview

Corporate Details

ISIN(s):
IT0004356751
LEI:
8156002B06C3A4C0F436
Country:
Italy
Address:
VIALE PAPA ACHILLE, 30, 20149 MILANO

Description

Enervit is a company specializing in the research, development, and production of sports nutrition, functional foods, and innovative supplements. Operating with a fully in-house approach, it formulates and manufactures a comprehensive range of products designed to support athletic performance, fitness, and general well-being. The product portfolio includes energy gels, bars, sports drinks, protein-rich shakes, and specialized supplements. Enervit serves a diverse market, including professional athletes in endurance, strength, and team sports, as well as fitness enthusiasts and health-conscious individuals. The company offers distinct product lines: one for sports and active lifestyles, and another for balance and wellness, featuring products based on the 40-30-30 Zone diet principles and Omega-3 supplements. This approach is guided by a philosophy of 'Positive Nutrition,' which emphasizes scientific innovation to meet diverse nutritional needs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-14 12:36
Informazioni Essenziali PATTO PARASOCIALE
Italian 391.0 KB
2025-11-12 18:18
CS-Sottoscrizione di Nuovo Patto Parasociale - Avviso di Cessazione di Patto Pa…
Italian 320.0 KB
2025-11-12 12:55
CS - Calendario eventi societari 2026
Italian 221.1 KB
2025-11-12 12:54
CS - dati vendite al 30.09.2025
Italian 359.0 KB
2025-07-31 18:04
Rel. società di revisione
Italian 705.8 KB
2025-07-30 13:38
AVVISO di deposito Rel. Fin. Semestrale
Italian 583.6 KB
2025-07-30 13:37
CS Approvata Rel. Fin. Semestrale al 30.6.2025
Italian 498.6 KB
2025-07-30 13:36
Rel. Finanz. Semestrale al 30.06.2025
Italian 3.0 MB
2025-05-14 14:19
CS Dati Trimestrali Vendite al 31 marzo 2025
Italian 321.3 KB
2025-04-28 13:01
AVVISO pagamento Dividendo Esercizio 2024
Italian 146.3 KB
2025-04-28 12:59
Rendiconto Sintetico delle Votazioni
Italian 219.2 KB
2025-04-28 12:57
CS post Assemblea Ordinaria del 28.04.2025
Italian 273.4 KB
2025-04-07 11:25
Avviso su quot Deposito Rel Fin Annuale
Italian 582.8 KB
2025-04-07 11:23
CS - Deposito Relazione Finanziaria Annuale
Italian 164.3 KB
2025-04-07 11:07
Relazione sul Governo Societario Assemblea 2025 Esercizio 2024
Italian 991.9 KB

Automate Your Workflow. Get a real-time feed of all Enervit filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Enervit

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Enervit via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.